スポンサーリンク
Department Of Medicine Ii Kansai Medical University | 論文
- OE-261 The possibility of autologus platelet intramuscular infusion therapy to chronic ischemic desease.(Peripheral circulation/Vascular disease(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- Molecular Insights into Angiotensin II Type 1 and Type 2 Receptors:Expression, Signaling and Physiological Function and Clinical Application of Its Antagonists
- HMG-CoA Reductase Inhibitors Suppress Myosin Light Chain Phosphorylation in Cultured Smooth Muscle Cell
- Ultrasound Irradiation-Mediated Microbubble Destruction Enables Highly Efficient Local Delivery of Bone Marrow Cells into Ischemic Myocardium
- Therapeutic Myo-Angiogenesis for Ischemia-Induced Myocardial Remodeling by Transplantation of Autologous Bone Marrow Mononuclear Cells
- Clinical differences between brain natriuretic peptide and N-terminal pro-brain natriuretic peptide
- -0995-LEFT VENTRICULAR DIASTOLIC FILLING AFTER PTCA : EVALUATION FOR CORONARY RE-STENOSIS : THE 54th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
- THE EFFECT OF DECREASED AORTIC DISTENSIBILITY ON LEFT VENTRICULAR FUNCTION IN ESSENTIAL HYPERTENSIVE PATIENTS : Hypertension : 53 Annual Scientific Meeting, Japanese Circulation Society
- ASSESSMENT OF SIGNAL INTENSITY OF BLOOD FLOW IN PULMONARY ARTERY AND PERIPHERAL LUNG FIELD BY T1-WEIGHTED MAGNETIC RESONANCE IMAGING IN PULMONARY ARTERIAL HYPERTENSION.
- -0129-RESPONSE OF RIGHT VENTRICULAR EJECTION FRACTION TO BICYCLE EXERCISE IN RECENT MYOCARDIAL INFARCTION : EFFECT OF INTERVENTRICULAR SEPTUM
- Therapeutic Myocyte Regeneration Assessed by NOGA Electromechanical Mapping-coupled Bone Marrow Cell Implantation (BMI) into Chronic Myocardial Ischemia
- LEFT VENTRICULAR PERFORMANCE DURING ISOMETRIC EXERCISE IN PATIENTS WITH OLD MYOCARDIAL INFARCTION : Ventricular Function : 53 Annual Scientific Meeting, Japanese Circulation Society
- -548- LEFT VENTRICULAR REGIONAL FUNCTION AFTER ACUTE ANTERIOR MYOCARDIAL INFARCTION AMONG DIABETIC PATIENTS
- Angiotensin II Receptor Type 1 Antagonist Suppress Cardiac Fibrosis in Patients with End Stage Renal Disease (ESRD)